Sunshine Biopharma is a pharmaceutical company. Co.'s proprietary drug development activities are focused on the development of a small molecule called Adva-27a for the treatment of aggressive forms of cancer. Co.'s Canadian wholly owned subsidiary, Sunshine Biopharma Canada Inc. has licensing agreements with a primary pharmaceutical company for four prescription generic drugs for the treatment of breast cancer, prostate cancer and enlarged prostate. These four generic products are Anastrozole, Letrozole, Bicalutamide, and Finasteride. Co. develops Essential 9, a dietary supplement comprised of the nine amino acids which the human body cannot synthesize. The SBFM average annual return since 2022 is shown above.
The Average Annual Return on the SBFM average annual return since 2022 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SBFM average annual return since 2022 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SBFM average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|